Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sze Fai Yip

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Pathology|August 2, 2023
A specific early eluting peak in Bio-Rad Variant II cation-exchange high-performance liquid chromatography (CE-HPLC) for the screening of alpha-thalassaemia in a Chinese populationWing Kit Lam, Winnie Yim Fong Law, Tsz Fung Wong, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 19, 2023
Clinical, neuroimaging, and behavioural risk factors for neurocognitive impairment in Chinese patients with haemophilia: A multicentre studyYin Ting Cheung, Chung Tin Ma, Henry Hon Wai Lam, et al.
Hematology (Amsterdam, Netherlands)|August 21, 2015
Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosisHarinder Gill, Anskar Y H Leung, Chi-Chung Chan, et al.
Bone Marrow Transplantation|February 21, 2024
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MMHoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, et al.
Journal of Hematology & Oncology|June 12, 2012
Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTDChor Sang Chim, Albert Kwok Wai Lie, Eric Yuk Tat Chan, et al.
Haematologica|October 16, 2012
A polymorphism in the 3'-untranslated region of the NPM1 gene causes illegitimate regulation by microRNA-337-5p and correlates with adverse outcome in acute myeloid leukemiaChi Keung Cheng, Tsz Ki Kwan, Chi Ying Cheung, et al.
International Journal of Molecular Sciences|June 10, 2023
SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune ResponseHerbert Augustus Pitts, Chi-Keung Cheng, Joyce Sin Cheung, et al.
Cancer|March 27, 2018
Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective studyHarinder Gill, Rita Yim, Harold K K Lee, et al.
HLA|November 12, 2020
Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patientsYuk-Lin Yung, Chi-Keung Cheng, Hoi-Yun Chan, et al.
Therapeutic Advances in Hematology|April 25, 2022
The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gainHoi Ki Karen Tang, Chi Yeung Fung, Gareth J Morgan, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Pathology|August 2, 2023
A specific early eluting peak in Bio-Rad Variant II cation-exchange high-performance liquid chromatography (CE-HPLC) for the screening of alpha-thalassaemia in a Chinese populationWing Kit Lam, Winnie Yim Fong Law, Tsz Fung Wong, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 19, 2023
Clinical, neuroimaging, and behavioural risk factors for neurocognitive impairment in Chinese patients with haemophilia: A multicentre studyYin Ting Cheung, Chung Tin Ma, Henry Hon Wai Lam, et al.
Hematology (Amsterdam, Netherlands)|August 21, 2015
Clinicopathologic features and prognostic indicators in Chinese patients with myelofibrosisHarinder Gill, Anskar Y H Leung, Chi-Chung Chan, et al.
Bone Marrow Transplantation|February 21, 2024
Prognostic factors in 448 newly diagnosed multiple myeloma receiving bortezomib-based induction: impact of ASCT, transplant refusal and high-risk MMHoi Ki Karen Tang, Chi Yeung Fung, Yu Yan Hwang, et al.
Journal of Hematology & Oncology|June 12, 2012
Treatment outcome and prognostic factor analysis in transplant-eligible Chinese myeloma patients receiving bortezomib-based induction regimens including the staged approach, PAD or VTDChor Sang Chim, Albert Kwok Wai Lie, Eric Yuk Tat Chan, et al.
Haematologica|October 16, 2012
A polymorphism in the 3'-untranslated region of the NPM1 gene causes illegitimate regulation by microRNA-337-5p and correlates with adverse outcome in acute myeloid leukemiaChi Keung Cheng, Tsz Ki Kwan, Chi Ying Cheung, et al.
International Journal of Molecular Sciences|June 10, 2023
SPINK2 Protein Expression Is an Independent Adverse Prognostic Marker in AML and Is Potentially Implicated in the Regulation of Ferroptosis and Immune ResponseHerbert Augustus Pitts, Chi-Keung Cheng, Joyce Sin Cheung, et al.
Cancer|March 27, 2018
Long-term outcome of relapsed acute promyelocytic leukemia treated with oral arsenic trioxide-based reinduction and maintenance regimens: A 15-year prospective studyHarinder Gill, Rita Yim, Harold K K Lee, et al.
HLA|November 12, 2020
Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patientsYuk-Lin Yung, Chi-Keung Cheng, Hoi-Yun Chan, et al.
Therapeutic Advances in Hematology|April 25, 2022
The impact of bortezomib-based induction in newly diagnosed multiple myeloma with chromosome 1q21 gainHoi Ki Karen Tang, Chi Yeung Fung, Gareth J Morgan, et al.
Pageof 4